Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) shares reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $307.00 and last traded at $300.50, with a volume of 92730 shares traded. The stock had previously closed at $303.45.
Direxion Daily S&P Biotech Bull 3x Shares Stock Down 2.7%
The firm’s 50-day moving average price is $199.23 and its 200-day moving average price is $179.11.
Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Hedge funds have recently modified their holdings of the stock. Tower Research Capital LLC TRC raised its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 664.7% during the third quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock valued at $5,445,000 after purchasing an additional 50,564 shares during the period. Squarepoint Ops LLC boosted its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% in the second quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock valued at $9,171,000 after purchasing an additional 40,157 shares during the period. JPMorgan Chase & Co. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at $3,208,000. Virtu Financial LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter valued at $1,757,000. Finally, Barclays PLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at $893,000.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- AI Is Selling Off, But These 5 Stocks Could Benefit Next
- These 3 Stocks Offer Investors Exposure to the Functional Beverage Boom
- Alcoa’s $4.1 Billion South32 Deal: Opportunity Behind the 9% Drop
- 3 High-Yield Dividend Stocks With Real Capital Gains Potential in 2026
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
